You are here
Revive Therapeutics' experimental COVID treatment fails in late-stage study
Primary tabs
Thu, 2023-07-06 10:06 — mike kraft
Revive Therapeutics' experimental COVID treatment fails in late-stage study Canada-based Revive Therapeutics said on Thursday its experimental COVID-19 treatment did not meet the main goal of a late-stage study. Reuters
...
The company was evaluating the safety and efficacy of its oral treatment, bucillamine, in the study which enrolled 713 patients with mild to moderate COVID-19.
...
General Topic Tags:
Problem, Solution, SitRep, or ?:
Groups this Group Post belongs to:
Recent Comments